Publicaciones › Retinopatía diabética: clínica, función y progresión
Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti–Vascular Endothelial Growth Factor
Angiografía de campo amplio OCT y angiografía con fluoresceína para evaluar la no perfusión en retinopatía diabética y edema tratados con anti-factor de crecimiento endotelial vascular
| Año | 2019 |
|---|---|
| Fuente | Ophthalmology |
| Tipo | article · Journal Article, Research Support, Non-U.S. Gov't |
| Autores (8) | Aude Couturier, Pierre-Antoine Rey, Ali Erginay, Carlo Lavia, Sophie Bonnin, Bénédicte Dupas, Alain Gaudric, Ramin Tadayoni |
| Posición de Erginay | 3 de 8 |
| Citas | 220 (OpenAlex) |
| Enlaces | DOI 10.1016/j.ophtha.2019.06.022 · PubMed 31383483 · OpenAlex · Texto completo en acceso abierto |
| Líneas | Edema macular diabético y sus tratamientos Enfermedades vasculares, genéticas e inflamatorias de la retina Retinopatía diabética: clínica, función y progresión Imagen retiniana: OCT, OCT-angiografía y ultra-gran campo |
En pocas palabras
Se estudió el cambio en la no perfusión retiniana después del tratamiento con anti-factor de crecimiento endotelial vascular para el edema macular diabético. Se utilizaron dos técnicas de imagen: angiografía OCT de campo amplio y angiografía con fluoresceína de campo ultra amplio. Se encontró que no hubo reperfusión de los vasos sanguíneos en las áreas de no perfusión después del tratamiento.
Resumen divulgativo generado automáticamente a partir del resumen original; puede contener imprecisiones.
Resumen original
To assess change in retinal nonperfusion (NP) after anti-vascular endothelial growth factor (VEGF) therapy for diabetic macular edema (DME) using 2 different imaging modalities: swept-source widefield (SS-WF) OCT angiography (OCTA) and ultra-widefield (UWF) fluorescein angiography (FA). Observational case series. Ten eyes of 9 patients with severe nonproliferative diabetic retinopathy (NPDR) or proliferative DR (PDR) initiating 3 monthly anti-VEGF intravitreal injections for DME. All eyes were imaged with UWF color fundus photographs (CFPs), UWF FA, and SS-WF OCTA at baseline (M0) and 1 month after the third anti-VEGF injection (M3). All images were aligned and divided into 16 boxes for analysis of NP areas by 2 blinded retina specialists. The number of discrepancies between SS-WF OCTA and UWF FA regarding the detection of NP areas and small vessels passing through NP areas; assessment of DR severity on UWF CFP; and change in each NP area between M0 and M3: number of boxes/eye with presence of at least 1 NP area, number of arterioles or venules that disappeared or reappeared, and number of NP areas in which capillaries disappeared or reappeared. The diabetic retinopathy (DR) severity score improved by at least 1 stage in 8 of 10 eyes, with a significant decrease in the mean number of microaneurysms and retinal hemorrhages on UWF CFP at M3 versus M0 (n = 40±28 vs. 121±57; P = 0.0020) and regression of fundus neovascularization when present. All NP areas detected on FA were seen on SS-WF OCTA, but additional NP areas were detected on SS-WF OCTA at M0 in 29% (46/160) of boxes. No reperfusion of arterioles or venules was observed at M3 on FA or SS-WF OCTA. Retinal capillaries were only visible on OCTA, and no reperfusion in NP areas was observed even when a reduction in dark areas was visible on FA. No reperfusion of vessels or capillary network was detected in NP areas using 2 imaging techniques, UWF FA and SS-WF OCTA, in eyes with DR after 3 anti-VEGF injections. The detection rate of NP areas was higher with SS-WF OCTA than with UWF FA.